Acquisition of Dacarbazine 200 Mg, Asparaguinase 10,000 IU, Anastrazole 1 Mg, Pertuzumab 420 Mg/14 Ml, Leucovorin 50 Mg, Carboplatin 450 mg, Docetaxel 40 mg/Ml, Filgrastrim 300 Mcg/Ml for the Heas Cancer Fight Program

This tender document contains detailed specifications, requirements, and submission guidelines. Purchase access to view the full document including eligibility criteria, scope of work, and evaluation methodology.

The complete document includes all annexes, terms of reference, and bidding instructions required for your submission.

Contact the procuring entity directly for pre-bid inquiries and clarifications.